Cagiano R, Barfield R J, White N R, Pleim E T, Weinstein M, Cuomo V
Institute of Pharmacology, University of Bari, Italy.
Eur J Pharmacol. 1988 Nov 15;157(1):45-50. doi: 10.1016/0014-2999(88)90469-4.
Prenatal exposure to a dopamine receptor blocking agent such as haloperidol (given to the mother at a dose of 0.5 mg/kg s.c. from day 4 to day 15 of gestation) produced subtle behavioural changes in rat pups. Haloperidol decreased the rate of ultrasonic vocalization in 4-day-old male pups removed from the nest. The changes in ultrasonic emission elicited by in utero exposure to this neuroleptic were markedly different from those produced by its administration during the early postnatal period. Moreover, adult male rats treated prenatally with haloperidol exhibited a significant increase in the intensity of ultrasonic 22 kHz post-ejaculatory calls emitted during sexual behaviour. The duration of the period of the 22 kHz calls emission was also significantly increased by haloperidol treatment. These results confirm that ultrasonic vocalization in rats is a sensitive indicator of subtle changes in adverse treatments administered during development.
产前接触多巴胺受体阻断剂(如氟哌啶醇,在妊娠第4天至第15天以0.5mg/kg的皮下注射剂量给予母体)会使幼鼠产生细微的行为变化。氟哌啶醇降低了从巢中取出的4日龄雄性幼鼠的超声波发声频率。子宫内接触这种抗精神病药物引起的超声波发射变化与出生后早期给药引起的变化明显不同。此外,产前用氟哌啶醇治疗的成年雄性大鼠在性行为期间发出的22kHz射精后超声波叫声强度显著增加。氟哌啶醇治疗还使22kHz叫声发射期的持续时间显著增加。这些结果证实,大鼠的超声波发声是发育期间给予的不良处理中细微变化的敏感指标。